...structure until after absorption. Freund is managing director of Skyline Ventures. He was chairman of XenoPort Inc....

...LAS41008 , a dimethyl fumarate that targets NFE2L2, in Phase III testing to treat psoriasis. XenoPort Inc....

...to XenoPort’s close of $4.40 on May 20, the day before the deal was announced. XenoPort...
...which is approved in the U.S. to treat restless legs syndrome and manage postherpetic neuralgia. XenoPort...
...in 2015 sales of the drug. The companies expect the deal to close next quarter. XenoPort Inc....

...Specialty pharma Arbor Pharmaceuticals Inc. (Atlanta, Ga.) is acquiring XenoPort Inc. (NASDAQ:XNPT) for $7.03 per share, or...
...approved in the U.S. to treat restless legs syndrome (RLS) and to manage postherpetic neuralgia. XenoPort...
...million in 2015 sales of the drug. The acquisition price is a 60% premium to XenoPort's...

...XenoPort granted Dr. Reddy’s exclusive, U.S. rights to develop and commercialize XP23829 . XenoPort will receive...
...in regulatory milestones and $250 million in commercial milestones, plus royalties up to the mid-teens. XenoPort...
...trial to treat moderate to severe chronic plaque-type psoriasis. XenoPort declined to disclose additional details. XenoPort Inc....

...induces and activates the nuclear factor (erythroid-derived 2)-like 2 ( NFE2L2 ; NRF2 ) pathway. XenoPort...
...in regulatory milestones and $250 million in commercial milestones, plus royalties up to the mid-teens. XenoPort...
...also will receive $2.5 million upon the transfer of clinical trial materials to Dr. Reddy%27s. XenoPort...

...9-mo op loss ended 9/30 10/1/15 XenoPort Inc. (NASDAQ:XNPT) 14% to 155 $152.4 1.71 9/30/15 $66.7 XenoPort...

...the compound and other pipeline candidates to focus on commercializing Horizant gabapentin enacarbil. In September, XenoPort...
...approved in the U.S. to treat restless legs syndrome (RLS) and to manage postherpetic neuralgia. XenoPort Inc....

...Alcoholism (NIAAA) is conducting a Phase II trial of Horizant to treat alcohol use disorder. XenoPort...
...Tokyo, Japan) markets the transported prodrug of gabapentin in Japan as Regnite . In September, XenoPort...
...30, XenoPort had $170.4 million in cash and a six-month operating loss of $43.5 million. XenoPort Inc....

...MS). Almirall S.A. has LAS41008 , dimethyl fumarate, in Phase III testing to treat psoriasis. XenoPort Inc....